As part of pharmaphorum’s Eye on Innovation series, Richard Staines spoke to John Zibert, chief medical officer at LEO Pharma’s Innovation lab, about how the company wants to develop produc
In an exclusive interview, Andrew Thompson, co-founder of Proteus Digital Health, tells us how his company is convincing the industry to embrace digital medicine.
Paul Tredwell, vice president for specialty brands at Accord Healthcare says innovation is vital for success in today’s generics and biosimilars market.
The FDA has started a priority review of Bristol-Myers Squibb Opdivo in combination with cisplatin as a first-line therapy for advanced urothelial carcinoma (UC), setting
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio